Biotech Company Announces $22M Investment Led by Mike Goguen’s Firm
Inimmune, a Missoula-based biotech company founded by nationally recognized vaccine scientists, raised $22 million in Series A funding led by Two Bear Capital, a venture capital firm founded by Whitefish philanthropist Mike Goguen.
Inimmune plans to use the investment to advance at least two late-stage pre-clinical drug candidates in oncology and allergy through Phase I human clinical trials.
The $22 million is believed to be the largest round of Series A funding in Montana history.
Read about it here: